Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Spoladore

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
European Heart Journal|June 22, 2012
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidenceRoberto Spoladore, Martin S Maron, Rossella D'Amato, et al.
Current Pharmaceutical Design|November 11, 2008
Metabolic therapy of heart failureGabriele Fragasso, Anna Salerno, Roberto Spoladore, et al.
Giornale Italiano Di Cardiologia (2006)|May 25, 2023
[The fact about e-cigarettes and cardiovascular risk]Roberto Spoladore, Francesca Daus, Sara Pezzini, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
The point on the electronic cigarette more than 10 years after its introductionRoberto Spoladore, Francesca Daus, Sara Pezzini, et al.
Global Cardiology Science & Practice|April 2, 2014
Hypertrophic cardiomyopathy: The need for randomized trialsIacopo Olivotto, Benedetta Tomberli, Roberto Spoladore, et al.
Expert Opinion on Investigational Drugs|March 1, 2024
Current experimental and early investigational agents for cardiac fibrosis: where are we at?Claudio M Ciampi, Andrea Sultana, Paolo Ossola, et al.
Journal of Clinical Medicine|April 30, 2021
Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk StratificationLuigi Pannone, Giulio Falasconi, Lorenzo Cianfanelli, et al.
Recenti Progressi in Medicina|January 5, 2011
[Present trends and controversies in the use of beta-blockers in cardiovascular diseases]Roberto Spoladore, Gabriele Fragasso, Claudia Montanaro, et al.
Current Heart Failure Reports|January 29, 2008
New directions in the treatment of heart failure: targeting free fatty acid oxidationGabriele Fragasso, Roberto Spoladore, Giorgio Bassanelli, et al.
Expert Opinion on Investigational Drugs|September 7, 2025
Investigational agents for ischaemic cardiomyopathy treatment: preclinical and early phase insightsPaolo Ossola, Claudio Mario Ciampi, Francesco Politi, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
European Heart Journal|June 22, 2012
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidenceRoberto Spoladore, Martin S Maron, Rossella D'Amato, et al.
Current Pharmaceutical Design|November 11, 2008
Metabolic therapy of heart failureGabriele Fragasso, Anna Salerno, Roberto Spoladore, et al.
Giornale Italiano Di Cardiologia (2006)|May 25, 2023
[The fact about e-cigarettes and cardiovascular risk]Roberto Spoladore, Francesca Daus, Sara Pezzini, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|November 16, 2022
The point on the electronic cigarette more than 10 years after its introductionRoberto Spoladore, Francesca Daus, Sara Pezzini, et al.
Global Cardiology Science & Practice|April 2, 2014
Hypertrophic cardiomyopathy: The need for randomized trialsIacopo Olivotto, Benedetta Tomberli, Roberto Spoladore, et al.
Expert Opinion on Investigational Drugs|March 1, 2024
Current experimental and early investigational agents for cardiac fibrosis: where are we at?Claudio M Ciampi, Andrea Sultana, Paolo Ossola, et al.
Journal of Clinical Medicine|April 30, 2021
Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk StratificationLuigi Pannone, Giulio Falasconi, Lorenzo Cianfanelli, et al.
Recenti Progressi in Medicina|January 5, 2011
[Present trends and controversies in the use of beta-blockers in cardiovascular diseases]Roberto Spoladore, Gabriele Fragasso, Claudia Montanaro, et al.
Current Heart Failure Reports|January 29, 2008
New directions in the treatment of heart failure: targeting free fatty acid oxidationGabriele Fragasso, Roberto Spoladore, Giorgio Bassanelli, et al.
Expert Opinion on Investigational Drugs|September 7, 2025
Investigational agents for ischaemic cardiomyopathy treatment: preclinical and early phase insightsPaolo Ossola, Claudio Mario Ciampi, Francesco Politi, et al.
Pageof 7